Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial
Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page
- Check7 days agoChange DetectedThe bottom of the page shows Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a site version update rather than changes to trial details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's deployment without altering the study information.SummaryDifference0.0%

- Check28 days agoChange DetectedA new funding line indicating the 2016 U.S. NIH grant/contract was added to the study record. This addition provides funding attribution within the study's details.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.6.5 is now shown, replacing the previous v3.6.4, indicating a minor site update to the page template.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page’s revision tag in the footer was updated from v3.6.3 to v3.6.4, reflecting a small template/content update.SummaryDifference0.0%

- Check78 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a small platform update with no changes to the study details or navigation visible to users.SummaryDifference0.0%

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.